IMTX — Immatics N.V. stock price, charts and financials

QT32Immatics N.V.

Immatics N.V. (NASDAQ: IMTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
9.38
+0.36+3.99%
OverviewShort InterestFilings
IMTXQT32Immatics N.V.·NASDAQ
9.38+3.99%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 29, 20263Initial statement of beneficial ownership
Jun 25, 2026S-8Registration of employee benefit securities
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20266-KForeign issuer report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 02, 20266-KForeign issuer report
Jun 01, 20266-KForeign issuer report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 20266-KForeign issuer report
Apr 21, 20266-KForeign issuer report
Apr 17, 20266-KForeign issuer report
Mar 18, 20263Initial statement of beneficial ownership
Mar 18, 20263Initial statement of beneficial ownership
Mar 18, 20263Initial statement of beneficial ownership
Mar 18, 20263Initial statement of beneficial ownership
#1 / 25 of 183
Page
▼
/ 8